A Delaware judge on Monday dismissed Merck & Co’s lawsuit seeking to hold Bayer AG responsible for more talc-related liabilities stemming from its $14.2 billion purchase of Merck’s consumer care business in 2014. Vice Chancellor Nathan Cook of the Delaware …
The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck’s diabetes drugs Januvia and Janumet, were contaminated with a possible carcinogen. The agency said it would temporarily allow Merck to distribute drugs with …
Last month the Superior Court of New Jersey ruled insurers cannot use a policy exclusion to avoid covering about $1.4 billion in damages Merck & Co. said it suffered from a spring 2017 cyber attack known as NotPetya. The court …
The U.S. Supreme Court on Tuesday rejected Merck & Co. Inc.’s bid to revive a $2.54 billion jury verdict it won against rival drugmaker Gilead Sciences Inc. for infringing a patent in a dispute over a blockbuster hepatitis C treatment. …
By the time Deb Dellapena arrived for work at Merck & Co.’s 90-acre campus north of Philadelphia, there was a handwritten sign on the door: The computers are down. It was worse than it seemed. Some employees who were already …
By the time Kelly Pfaff got home from driving her son to school that morning, it was too late. Her husband, John, was supposed to be taking their 4-year-old daughter to school. But the girl and the nanny were still …
A prominent Chinese environmental group has called on chemicals multinationals to stop “cutting corners” by outsourcing business to Chinese suppliers that violate safety regulations after an investigation into a deadly explosion at a factory in March. In a new study, …
The U.S. Supreme Court on Monday gave Merck & Co. a new opportunity to avoid lawsuits accusing the company of failing to properly warn patients of debilitating thigh-bone fractures from taking its osteoporosis drug Fosamax, throwing out a lower court …
The U.S. Supreme Court on Thursday agreed to hear Merck & Co.’s appeal of a lower court’s ruling that revived hundreds of lawsuits accusing the company of failing to adequately warn patients of the risks of thigh bone fractures associated …
A U.S. appeals court on Wednesday affirmed a ruling that pharmaceutical company Merck & Co. dishonestly obtained patent rights and was not entitled to collect a $200 million infringement verdict it won against rival Gilead Sciences Inc. The U.S. Court …
